Inflammatory Chemokines in Atherosclerosis
Top Cited Papers
Open Access
- 25 January 2021
- Vol. 10 (2), 226
- https://doi.org/10.3390/cells10020226
Abstract
Atherosclerosis is a long-term, chronic inflammatory disease of the vessel wall leading to the formation of occlusive or rupture-prone lesions in large arteries. Complications of atherosclerosis can become severe and lead to cardiovascular diseases (CVD) with lethal consequences. During the last three decades, chemokines and their receptors earned great attention in the research of atherosclerosis as they play a key role in development and progression of atherosclerotic lesions. They orchestrate activation, recruitment, and infiltration of immune cells and subsequent phenotypic changes, e.g., increased uptake of oxidized low-density lipoprotein (oxLDL) by macrophages, promoting the development of foam cells, a key feature developing plaques. In addition, chemokines and their receptors maintain homing of adaptive immune cells but also drive pro-atherosclerotic leukocyte responses. Recently, specific targeting, e.g., by applying cell specific knock out models have shed new light on their functions in chronic vascular inflammation. This article reviews recent findings on the role of immunomodulatory chemokines in the development of atherosclerosis and their potential for targeting.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (SFB 1123)
This publication has 154 references indexed in Scilit:
- Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytesEMBO Molecular Medicine, 2013
- Fractalkine Is Expressed in Early and Advanced Atherosclerotic Lesions and Supports Monocyte Recruitment via CX3CR1PLOS ONE, 2012
- CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in miceJCI Insight, 2011
- Chemokines in health and diseaseExperimental Cell Research, 2011
- CXC Chemokine Ligand 4 Induces a Unique Transcriptome in Monocyte-Derived MacrophagesThe Journal of Immunology, 2010
- CXCL4 Downregulates the Atheroprotective Hemoglobin Receptor CD163 in Human MacrophagesCirculation Research, 2010
- Monocyte Chemoattractant Protein-1 (MCP-1): An OverviewJournal of Interferon & Cytokine Research, 2009
- Genomewide Association Analysis of Coronary Artery DiseaseThe New England Journal of Medicine, 2007
- A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor developmentThe Journal of Experimental Medicine, 2006
- The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tractNature, 1998